Skip to main content

Infectious Disease General

RSS  

Articles

  • New Insights into the Antimicrobial Susceptibility of Stenotrophomonas maltophilia

    Stenotrophomonas maltophilia is an opportunistic gram-negative bacillus with intrinsic resistance to a variety of antibiotics. Since clinical trial data are lacking, the optimal antimicrobial regimen is unknown. These factors make S. maltophilia increasingly challenging for the treating clinician. A recent study by Sader and colleagues analyzed the antimicrobial susceptibility of 1,400 S. maltophilia isolates collected from U.S. medical centers between 2019 and 2023. Aztreonam-avibactam, which inhibited 99.6% of isolates at ≤ 8 mcg/mL, was found to have the highest levels of in vitro activity. Trimethoprim-sulfamethoxazole, which has historically been a preferred agent, had slightly lower activity (96.9% susceptible), followed by minocycline (89.2%) and levofloxacin (78.9%). The results from this in vitro study suggest that aztreonam-avibactam may be a highly effective option for treating S. maltophilia infections, especially in multidrug-resistant cases.

  • Bacterial Vaginosis: Treat the Man, Too

    In a randomized trial, treatment of the regular male partner with oral and topical agents was strongly associated with a reduced risk of recurrence of bacterial vaginosis in the female partner.

  • Malaria Management: From ACT to TACT

    Artemisinin resistance of Plasmodium falciparum is expanding in Southeast Asia and in parts of Africa. Among older children and adults in West Africa, the addition of low-dose primaquine to standard artemisinin combination therapy successfully blocked gametocyte survival and parasite transmission.

  • Measles Vaccination in Adults in 2025

    The Centers for Disease Control and Prevention has updated measles vaccination recommendations.

  • Shortages of Antimicrobial Agents

    Shortages of antimicrobial drugs are frequent and represent a danger to patients and to public health.

  • Infectious Disease Updates

    Post-COVID Cryptococcosis — Even in Those Without Immunosuppression; Think Tularemia

  • RSV Vaccination in Severely Immunocompromised Individuals

    The antibody response to respiratory syncytial virus vaccination is significantly impaired in many severely immunocompromised individuals.

  • Agreeing to Care for Unvaccinated Children

    Many primary care clinicians choose not to enroll pediatric patients in their practices when the parents disagree with standard childhood immunization. However, such refusal to provide primary care raises significant controversy and ethical concerns.

  • A Plasma Cell-Free DNA PCR Panel Test for Invasive Mold Disease

    Lieu and colleagues performed a retrospective study of patients with suspected invasive mold disease that showed a high degree of concordance between noninvasive plasma cell-free deoxyribonucleic acid (DNA) polymerase chain reaction (PCR) testing and invasive specimen fungal test results.

  • Clostridioides difficile Toxin Vaccine Failed to Prevent Primary Infection in Trial

    A Phase III randomized clinical trial on adults 50 years of age and older found that a detoxified toxin A/B vaccine failed to reach its primary endpoint of preventing Clostridioides difficile infection. The vaccine was safe and well tolerated.